TY - JOUR
T1 - Risk stratification based on screening history
T2 - The NELSON lung cancer screening study
AU - Yousaf-Khan, Uraujh
AU - Van Der Aalst, Carlijn
AU - De Jong, Pim A.
AU - Heuvelmans, Marjolein
AU - Scholten, Ernst
AU - Walter, Joan
AU - Nackaerts, Kristiaan
AU - Groen, Harry
AU - Vliegenthart, Rozemarijn
AU - Ten Haaf, Kevin
AU - Oudkerk, Matthijs
AU - De Koning, Harry
N1 - Publisher Copyright:
© Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-And-licensing/.
PY - 2017/9/1
Y1 - 2017/9/1
N2 - Background Debate about the optimal lung cancer screening strategy is ongoing. In this study, previous screening history of the Dutch-Belgian Lung Cancer Screening trial (NELSON) is investigated on if it predicts the screening outcome (test result and lung cancer risk) of the final screening round. Methods 15â €..792 participants were randomised (1:1) of which 7900 randomised into a screening group. CT screening took place at baseline, and after 1, 2 and 2.5â €..years. Initially, three screening outcomes were possible: negative, indeterminate or positive scan result. Probability for screening outcome in the fourth round was calculated for subgroups of participants. Results Based on results of the first three rounds, three subgroups were identified: (1) those with exclusively negative results (n=3856; 73.0%); (2) those with ≥1 indeterminate result, but never a positive result (n=1342; 25.5%); and (3) with ≥1 positive result (n=81; 1.5%). Group 1 had the highest probability for having a negative scan result in round 4 (97.2% vs 94.8% and 90.1%, respectively, p<0.001), and the lowest risk for detecting lung cancer in round 4 (0.6% vs 1.6%, p=0.001). â € Smoked pack-years' and â € screening history' significantly predicted the fourth round test result. The third round results implied that the risk for detecting lung cancer (after an interval of 2.5â €..years) was 0.6% for those with negative results compared with 3.7% of those with indeterminate results. Conclusions Previous CT lung cancer screening results provides an opportunity for further risk stratifications of those who undergo lung cancer screening. Trial registration number Results, ISRCTN63545820.
AB - Background Debate about the optimal lung cancer screening strategy is ongoing. In this study, previous screening history of the Dutch-Belgian Lung Cancer Screening trial (NELSON) is investigated on if it predicts the screening outcome (test result and lung cancer risk) of the final screening round. Methods 15â €..792 participants were randomised (1:1) of which 7900 randomised into a screening group. CT screening took place at baseline, and after 1, 2 and 2.5â €..years. Initially, three screening outcomes were possible: negative, indeterminate or positive scan result. Probability for screening outcome in the fourth round was calculated for subgroups of participants. Results Based on results of the first three rounds, three subgroups were identified: (1) those with exclusively negative results (n=3856; 73.0%); (2) those with ≥1 indeterminate result, but never a positive result (n=1342; 25.5%); and (3) with ≥1 positive result (n=81; 1.5%). Group 1 had the highest probability for having a negative scan result in round 4 (97.2% vs 94.8% and 90.1%, respectively, p<0.001), and the lowest risk for detecting lung cancer in round 4 (0.6% vs 1.6%, p=0.001). â € Smoked pack-years' and â € screening history' significantly predicted the fourth round test result. The third round results implied that the risk for detecting lung cancer (after an interval of 2.5â €..years) was 0.6% for those with negative results compared with 3.7% of those with indeterminate results. Conclusions Previous CT lung cancer screening results provides an opportunity for further risk stratifications of those who undergo lung cancer screening. Trial registration number Results, ISRCTN63545820.
KW - Clinical Epidemiology
KW - Lung Cancer
KW - Smoking cessation
KW - Tobacco and the lung
UR - http://www.scopus.com/inward/record.url?scp=85029385622&partnerID=8YFLogxK
U2 - 10.1136/thoraxjnl-2016-209892
DO - 10.1136/thoraxjnl-2016-209892
M3 - Article
C2 - 28360223
SN - 0040-6376
VL - 72
SP - 819
EP - 824
JO - Thorax
JF - Thorax
IS - 9
ER -